All news

LEO Pharma owners say market conditions unsuitable for IPO, casting doubt on 2026 listing

Reuters (via 104.9 The Wolf) · · AI-summarised by FinFlash

LEO Pharma CEO Christophe Bourdon said the Danish drugmaker's owners do not consider current market conditions right for a listing, casting doubt on plans to float before end-2026. He still called an IPO a natural and viable option, depending on performance and investor appetite. The LEO Foundation owns 80% and Nordic Capital the rest after investing 450 million euros in 2021. Earlier reports had flagged a Copenhagen listing.

So What?

Another sign of a cooling European IPO window as AI-driven volatility hits markets; delays supply of new listings on Nasdaq Copenhagen.

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.